IACT Health has partnered with Virginia Gastroenterology Institute (VGI) in Suffolk, Virginia to conduct clinical trial research in gastroenterology. Established in 2015, VGI provides comprehensive care as gastrointestinal and liver specialists throughout the Hampton Road’s area including Suffolk, Chesapeake, Portsmouth, Virginia Beach, Norfolk, and the Peninsula areas of the Tidewater region. Dr. Pramod Malik was the first Certified Principal Investigator in Hampton Roads and in 2008, was one of the first in the U.S. to be certified by the Association of Clinical Research Professionals (ACRP). He has conducted clinical trials in gastroesophageal reflux disease (GERD), gastroparesis, bleeding peptic ulcer, ulcerative colitis, Crohn’s disease, and irritable bowel syndrome.

“Dr. Malik has an immense amount of experience in Gastroenterology research and we’re thrilled to add his research business to the IACT Health portfolio of companies. Together, we will dramatically expand the GI research performed in the Hampton Roads region of Virginia which will be of huge value to the patients in these communities,” said Dr. Jeffrey Kingsley, CEO of IACT Health.

Dr. Pramod Malik stated that “I have been involved in clinical trials as an individual GI group practice since 2002. In 2020, having joined hands with IACT, my team and I are very excited about the partnership with IACT Health in the area of cutting-edge research in Gastroenterology. This partnership is going to tie right into our overall mission and vision in providing GI services to improve lives of patients and their families in the community we serve and the world as a whole. By developing this partnership, we aspire to help improve the disease management outcomes by conducting scientific clinical trials of the highest quality with a much greater efficiency.”

About IACT Health:
IACT Health strives to revolutionize research by conducting clinical trials with dedicated research professionals across the Southeast in more than 30 therapeutic areas. Every member of the team specializes in one very specific role within the company. IACT Health delivers focused care and is dedicated to creating outstanding clinical trial experiences, improving outcomes, and lowering the risk and net cost of studies. IACT Health’s proven enrollment is over 200% of the average research site, as assessed by Tufts University. IACT Health is committed to enhancing overall efficiency, speed, quality, and accuracy in today’s clinical site model. For more information on IACT Health: https://www.iacthealth.com

Media Contact:

Felicia Irvin
Director of Sales and Marketing
IACT Health